Peptide Characterization

Introduction: The Sameness Evaluation of Synthetic Peptides for ANDA is a critical regulatory requirement that ensures generic synthetic peptide drugs […]

Introduction: Orthogonal Analytical Techniques for ANDA Sameness Evaluation play a crucial role in demonstrating that a generic drug product is

Introduction: The Lanreotide Sameness Study is a comprehensive analytical exercise designed to prove that a generic lanreotide product is identical to the

Introduction: Analytical Strategies for Sameness Study are fundamental in demonstrating that a generic drug is equivalent to its Reference Listed

Introduction: Active Ingredient Sameness in ANDA is demonstrated by proving that the generic drug’s API is identical to the Reference

Introduction: Sameness Evaluation in ANDA is the scientific and regulatory process of proving that a generic drug’s active ingredient is

Introduction: GLP-1 Peptide Mapping Regulatory Requirements are central to demonstrating biosimilarity and structural integrity in generic drug development. Regulatory authorities

Introduction: GLP-1 impurity peptide mapping is a powerful analytical approach used to detect and characterize impurities and degradation pathways in

Introduction: When it comes to GLP-1 Peptide Mapping vs Intact Mass, choosing the right analytical approach depends on your objective—whether